Dispensing of long-term treatments for multiple sclerosis in the pharmacy

被引：0
|
作者：
Voirin, Maelle [1 ]
机构：
[1] 65 Ave Raymond Poincare, F-21000 Dijon, France
来源：
ACTUALITES PHARMACEUTIQUES | 2018年 / 57卷 / 573期
关键词：
adverse effect; compliance; dispensing; injectable biotherapy; oral form; treatment switching;
D O I：
10.1016/j.actpha.2017.11.026
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The therapeutic armamentarium for patients with multiple sclerosis has evolved over recent years. When dispensing long-term treatments, pharmacists must inform and advise, optimise the management of the treatment, detect adverse effects and ensure compliance. When a treatment is changed, the monitoring must be stepped up. (c) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：26 / 30
页数：5
相关论文
共 50 条
  • [31] LONG-TERM TREATMENT OF MULTIPLE-SCLEROSIS WITH AZATHIOPRINE
    SWINBURN, WR
    LIVERSEDGE, LA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1973, 36 (01): : 124 - 126
  • [32] Long-term interferon-β treatment for multiple sclerosis
    R. M. Ruggieri
    N. Settipani
    L. Viviano
    M. Attanasio
    L. Giglia
    P. Almasio
    V. La Bella
    F. Piccoli
    Neurological Sciences, 2003, 24 : 361 - 364
  • [33] Psychiatric illness in long-term multiple sclerosis cohort
    Tham, J.
    Traboulsee, A.
    Oger, J.
    MULTIPLE SCLEROSIS, 2006, 12 : S147 - S148
  • [34] Long-term phonatory instability in individuals with multiple sclerosis
    Hartelius, L
    Buder, EH
    Strand, EA
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 1997, 40 (05): : 1056 - 1072
  • [35] Long-term safety of mitoxantrone therapy for multiple sclerosis
    Mulroy, E.
    Joyce, E.
    Scott, J.
    Melling, J.
    Goggin, C.
    Mahon, N.
    O''Rourke, K. E. T.
    Lynch, T.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S445 - S445
  • [36] Long-term interferon-β treatment for multiple sclerosis
    Ruggieri, RM
    Settipani, N
    Viviano, L
    Attanasio, M
    Giglia, L
    Almasio, P
    La Bella, V
    Piccoli, F
    NEUROLOGICAL SCIENCES, 2003, 24 (05) : 361 - 364
  • [37] Long-term trajectories of ambulatory impairment in multiple sclerosis
    Gunzler, Douglas D.
    De Nadai, Alessandro S.
    Miller, Deborah M.
    Ontaneda, Daniel
    Briggs, Farren B. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (10) : 1282 - 1295
  • [38] Long-term treatment of multiple sclerosis with IgG immunotherapy
    Schuller, E
    Lambin, P
    Deloche, G
    PATHOLOGIE BIOLOGIE, 1996, 44 (08): : 710 - 715
  • [39] Long-term effects of intrathecal baclofen in multiple sclerosis
    Natale, Massimo
    D'Oria, Salvatore
    Nero, Veronica Venera
    Squillante, Eleonora
    Gentile, Marisa
    Rotondo, Michele
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2016, 143 : 121 - 125
  • [40] LONG-TERM EFFICACY OF OCRELIZUMAB IN RELAPSING MULTIPLE SCLEROSIS
    Giovannoni, Gavin
    Hauser, Stephen L.
    Brochet, Bruno
    Montalban, Xavier
    Naismith, Robert T.
    Wolinsky, Jerry S.
    Hubeaux, Stanislas
    Mehta, Lahar
    Model, Fabian
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
12345